Pharma Journalist -

Roche announced that the European Commission has granted approval for Gazyva®/Gazyvaro® (obinutuzumab) combined with mycophenolate mofetil (MMF) to treat adults with active Class III or…
Read More...

Inductive Bio, an AI-driven drug discovery company known for developing virtual chemistry laboratories, has been awarded up to $21 million to lead a groundbreaking project aimed at…
Read More...

Viatris Inc. has entered into definitive agreements with Biocon Limited for the sale of its full equity stake in Biocon Biologics Limited, marking a major strategic move as the company…
Read More...

January 27-29, 2026 | Boston, MA – With the exciting news of Novartis acquiring Avidity Biosciences, SanegeneBio and Eli Lilly's partnership worth $1.2B to develop RNAi therapeutics for…
Read More...

Ionis Pharmaceuticals has received a significant boost in its neurology pipeline with the U.S. Food and Drug Administration granting Breakthrough Therapy designation to zilganersen, the…
Read More...

Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted expanded approval for Jaypirca (pirtobrutinib) for adults with relapsed or refractory…
Read More...

Taiwan-based Formosa Pharmaceuticals (6838.TW) has entered into an exclusive licensing agreement with Singapore-headquartered Rxilient Medical Pte. Ltd., granting the company…
Read More...

Global biopharmaceutical contract development and manufacturing organization (CDMO) AGC Biologics has announced a major expansion of its Cell Line Development Center of Excellence…
Read More...

The U.S. Food and Drug Administration (FDA) has appointed Tracy Beth Høeg, M.D., Ph.D., as the acting director of the Center for Drug Evaluation and Research (CDER), marking a…
Read More...

The U.S. Food and Drug Administration (FDA) has issued new draft guidance identifying specific drug product types for which six-month non-human primate (NHP) toxicity studies can be…
Read More...